Zhiyun Health Strengthens Digital Infrastructure and Upgrades AI-Driven Capabilities with Enhanced SaaS Solutions
As a leader in the digital healthcare sector, Zhiyun Health has consistently maintained the drive and resilience of a startup throughout its development. The company continuously optimizes its strategic direction while deepening its advantages in digital infrastructure to build diversified digital solutions. Empowered by the AI technology of the Zhiyun Medical Brain, Zhiyun Health enhances its digital capabilities and launches comprehensive digital solutions tailored to scenarios such as in-hospital care, pharmacy services, and personal chronic disease management, thereby achieving diverse commercial applications.
It has been over a year since Zhiyun Health listed on the Hong Kong Stock Exchange. Over the past year, in addition to the sustained growth of its traditional business, Zhiyun Health has also made frequent moves in the digital healthcare sector.
On the one hand, the company continues to drive the development of its traditional business, achieving effective connectivity among hospitals, pharmacies, pharmaceutical companies, physicians, and patients. On the other hand, Zhiyun Health is steadily increasing its R&D investment in core technologies and accumulating expertise in medical artificial intelligence, expanding “AI + digitalization” application scenarios, continuously enhancing its digital capabilities, and further solidifying its leading position in this field.
The company has not only successfully upgraded its ClouDr Brain, but also built two major healthcare industry models, ClouD GPT and ClouD DTx, to drive assisted clinical diagnosis and drug and medical device R&D, respectively. Meanwhile, as its digital therapeutics have gained further scientific validation, the company has become one of the first ecosystem partners of Baidu’s ERNIE Bot. This partnership enables ChatGPT-like technologies to be applied in areas such as health science popularization, online consultations, pharmaceutical services, and personal health management, thereby promoting the sustainable development of the company’s business and products.
The continuous enhancement of Zhiyun Health’s digital capabilities is driving ongoing upgrades to its products and services, better empowering ecosystem partners and paving a smoother path toward commercialization.
As one of the early entrants in China’s digital chronic disease management and internet healthcare sectors, Zhiyun Health maintains deep insights and keen judgment on industry trends. This strategic acumen was precisely what enabled the company to break through the fierce competition known as the “Hundred Glucose Wars.”
At that time, Zhiyun Health made a pivotal decision that set it apart from most industry participants: it abandoned its consumer-centric (C-end) approach and pivoted to the business side (B-end), starting with hospitals. By adopting a “hospital-first” strategy, the company transformed its business model. This strategic shift enabled Zhiyun Health to steadily raise industry barriers, accumulate substantial business data and digital technologies, and lay a solid foundation for future growth, thereby allowing it to continuously expand its business scope.
Subsequently, Zhiyun Health leveraged its SaaS-based chronic disease management services for hospitals as an entry point, focusing on hospital operations and driving business upgrades along the trajectory of digitalization and intelligence. By establishing three core business pillars—a Hospital SaaS system, a Pharmacy SaaS system, and an Internet Hospital platform—Zhiyun Health successfully achieved effective connectivity among all stakeholders. Its core business has gradually expanded to cover comprehensive digital management of chronic diseases throughout their entire lifecycle, both within and outside hospital settings. This has created a closed-loop solution for full-lifecycle chronic disease management centered around key industry participants, including hospitals, physicians, patients, pharmaceutical companies, and pharmacies. As one of the influential enterprises in the industry, Zhiyun Health was listed on the Hong Kong Stock Exchange in 2022.
After successfully listing on the secondary market, Zhiyun Health has not ceased its exploration.
Leveraging the rich data assets accumulated over years in the field of digital chronic disease management, along with its capabilities in developing digital tools, Zhiyun Health has built a digital medical technology system driven by dual middle platforms for data and business. While conducting its core operations, the company utilizes advanced digital technologies to establish various medical databases related to prevention, diagnosis, and treatment, thereby forming its digital infrastructure.
By operating systems such as Zhiyun Yihui SaaS, Zhiyun Consultation SaaS, and Zhiyun Internet Hospital in real-world medical scenarios, and further empowered by the advanced AI technology platform—Zhiyun Medical Brain, Zhiyun Health is able to continuously optimize and iterate its products and services, promote diversified business expansion, and provide a steady stream of momentum for the company’s sustainable development.
Empowered by the AI technology of Zhiyun Medical Brain, Zhiyun Health’s digital capabilities have been further enhanced. Not only have the boundaries of its digital and intelligent business operations continued to expand, but it has also made sustained progress in areas such as AI-assisted clinical diagnosis, pharmaceutical and medical device R&D, and digital therapeutics. The company has now reached the stage of productization and commercialization in its “AI + Healthcare” applications.
Despite more than two decades of growth in internet healthcare driven by market forces and policy support, companies that fail to develop viable, profitable business models face imminent risk of being pushed out of the market amid rapidly changing conditions. Even today, every participant must maintain a “primal sense of crisis,” engaging in self-reflection, continuously accumulating experience, and persistently exploring new pathways for industry development.
Looking back at the journey of Zhiyun Health, it is evident that the company has adhered to its “Hospital-First” strategy. By independently developing hospital SaaS systems, pharmacy SaaS systems, and an internet hospital platform, Zhiyun Health has successfully secured a prominent position in the industry and upgraded from specializing in diabetes management to becoming China’s largest provider of digital chronic disease management solutions. The company has not rested on its laurels; while maintaining growth in its core business, Zhiyun Health continues to increase R&D investment in core technologies, vigorously explore the value of medical artificial intelligence, and continuously enhance its digital service capabilities.
What is the driving force behind Zhiyun Health’s continued growth and increasing success?
Perhaps it is the relentless momentum provided by the digital foundation laid by ZhiiYun Health as a pioneer in building digital infrastructure for the chronic disease management industry that fuels its business expansion. Perhaps it is the process of transforming around key industry challenges, continuously validating its value, and adjusting its strategic focus. Or perhaps it is both. After all, in an era of constant industry evolution, there is no fixed anchor in digital health. Industry participants must continually engage in self-reflection, identify their “heterogeneity,” and persistently explore new paths for industry development.
From a technical perspective, Zhiyun Health possesses both AI R&D capabilities and information security assurance capabilities, with mature experience in developing digital tools and solutions. In addition, Zhiyun Health’s medical team has established standardized and procedural mechanisms for data element processing. Leveraging its self-developed AI platform, the company has completed multiple scientific studies, published high-quality papers in prestigious international journals, and participated in the drafting and formulation of numerous industry standards and consensus guidelines.
In the future, Zhiyun Health will continue to leverage its strengths in the digital domain, guided by market demand and driven by technological innovation. The company is committed to delivering more efficient, convenient, and intelligent healthcare services, working with industry partners to usher in a new era of mutual benefit and win-win cooperation in digital health. Ultimately, this will facilitate the comprehensive integration of digital dividends into the healthcare sector, promoting its transformation and upgrading.